Home
Live Updates
Disease Modifying Therapies for Children with Spinal Atrophy : vimarsana.com
Disease Modifying Therapies for Children with Spinal Atrophy
An update on the emerging evidence of the effects and safety of disease modifying therapies for the management of children with spinal muscular atrophy (SMA).
Related Keywords
Germany ,
Australia ,
Japan ,
Hungary ,
Netherlands ,
Philadelphia ,
Pennsylvania ,
United States ,
Wieringen ,
Noord Holland ,
Schoneborn ,
Nordrhein Westfalen ,
Crawford ,
Queensland ,
Switzerland ,
Bonn ,
France ,
Hagenacker ,
Bayern ,
Australian ,
Holland ,
French ,
Hungarian ,
Nat Genet ,
Hansa Biopharma ,
Petzolda Neurofilament ,
Clin Neurophysiol ,
Sanofi Genzyme ,
Thomas Sejersen ,
Neuromuscul Disord ,
Pediatr Pulmonol ,
Dement Neuropsychol ,
Zetterbergh Neurofilament ,
Dunaway Young ,
Dhillons Risdiplam ,
World Muscle Society Virtual Congress ,
Charles River Associates ,
European Medicines Agency ,
Us Food Drug Administration ,
Lancet Child Adolesc Health ,
Novartis ,
Sarepta Therapeutics ,
Clin North ,
Treat Options ,
Opin Investig ,
Child Adolesc ,
Orphanetj Rare ,
Clin Transl ,
Ther Methods Clin ,
Spinal Muscular Atrophy ,
Clin Risk ,
Huangy T ,
Neurol Neurosurg ,
Philadelphia Infant Test ,
Neuromuscular Disorders ,
Hammersmith Functional Motor Scale ,
Chaej H ,
Chieny H ,
vimarsana.com © 2020. All Rights Reserved.